Recent developments in health and medical science highlight significant advancements in cancer treatment, strategic shifts in the biotech industry, and the growing role of AI in healthcare.

The FDA has granted two new indications for sacituzumab govitecan (Trodelvy) in metastatic triple-negative breast cancer. In another promising cancer breakthrough, an existing FDA-approved drug, AMD3100, has been found to significantly improve the effectiveness of immunotherapy against rare liver cancer by...